Suppr超能文献

[使用维拉帕米预防运动诱发的室性心律失常]

[Prevention of effort-induced ventricular arrhythmia using verapamil].

作者信息

Gülker H, Godejohann U, Dorsel T, Behrenbeck T, Heuer H, Bender F

机构信息

Medizinische Klinik und Poliklinik (Abteilung Innere Medizin C), Westfälische Wilhelms-Universität Münster.

出版信息

Z Kardiol. 1987 Jul;76(7):404-10.

PMID:3673161
Abstract

In this study prophylactic antiarrhythmic effects of verapamil on exercise-induced ventricular arrhythmias were evaluated in a total of 22 patients. All patients displayed frequent and/or complex ventricular arrhythmias during repeated exercise tests under control conditions. After two control exercise tests, all patients were treated with 120 mg verapamil given every 8 h orally for 4 days. On the 3rd and 4th day of treatment the exercise tests were repeated. The results were that verapamil caused a significant reduction in the incidence and severity of exercise-induced ventricular arrhythmias in 13 out of 22 patients. In patients with concomitant significant ST-segment depression, a prophylactic action could be demonstrated in nine out of ten cases. The antiarrhythmic effect was independent of changes in heart rate. In patients with myocardial ischaemia, a reduction in myocardial oxygen consumption and direct electrophysiological effects (suppression of the "slow response" and/or an increase in the resting potential of the "depressed fast response") can be discussed as mechanisms of action. Also, a suppression of "triggered activity" or a direct inhibition of adrenergic effects must be considered. According to our results and the literature, calcium antagonists (verapamil type) proved to be suitable drugs for the treatment of exercise-induced ventricular arrhythmias, particularly in patients with concomitant myocardial ischaemia.

摘要

在本研究中,对总共22例患者评估了维拉帕米对运动诱发室性心律失常的预防性抗心律失常作用。所有患者在对照条件下的重复运动试验期间均表现出频繁和/或复杂的室性心律失常。在进行两次对照运动试验后,所有患者接受口服维拉帕米120 mg,每8小时一次,共4天的治疗。在治疗的第3天和第4天重复进行运动试验。结果显示,22例患者中有13例维拉帕米使运动诱发室性心律失常的发生率和严重程度显著降低。在伴有明显ST段压低的患者中,10例中有9例可证明有预防作用。抗心律失常作用与心率变化无关。在心肌缺血患者中,可将心肌耗氧量降低和直接电生理效应(抑制“慢反应”和/或提高“压低的快反应”的静息电位)作为作用机制进行讨论。此外,必须考虑抑制“触发活动”或直接抑制肾上腺素能效应。根据我们的结果和文献,钙拮抗剂(维拉帕米类)被证明是治疗运动诱发室性心律失常的合适药物,特别是在伴有心肌缺血的患者中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验